Literature DB >> 7351016

Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.

E R Fisher, C K Redmond, H Liu, H Rockette, B Fisher.   

Abstract

Estrogen receptor (ER) status was correlated with a large number of pathological and clinical characteristics of 178 invasive breast cancers. Positive ER was found to be significantly associated with high nuclear and low histologic grades, absence of tumor necrosis, presence of marked tumor elastosis, and older patients. These pathologic parameters enumerated are either directly or indirectly related to tumor differentiation suggesting that ER represents another index of this latter. Multivariate analyses disclosed that both age and tumor differentiation are associated with the ER status. Well-differentiated tumors were more frequently ER+ in older women. Inclusion of an estimate of tumor necrosis as well as patient age appears to allow for further discrimination of ER status in poorly differentiated lesions. Considerations relative to ER and tumor differentiation provide a possible explanation for the dichotomy of response to adjuvant chemotherapy observed in pre and postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7351016     DOI: 10.1002/1097-0142(19800115)45:2<349::aid-cncr2820450226>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Hormone receptor status of breast cancer in the himalayan region of northern India.

Authors:  Rashmi Kaul; Jaishree Sharma; Satinder S Minhas; Kavita Mardi
Journal:  Indian J Surg       Date:  2010-12-14       Impact factor: 0.656

2.  Scar and non-scar ductal cancer of the female breast. Observations on patient age, tumour size, and hormone receptors.

Authors:  S Partanen; H Hyvärinen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Polypeptide composition of normal and neoplastic human breast tissues and cells analyzed by two-dimensional gel electrophoresis.

Authors:  T M Maloney; P L Paine; J Russo
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

4.  Histochemical demonstration of endogenous estrogen in breast carcinomas: biochemical and clinical correlation.

Authors:  I Katayama; M Shimizu; M Miura; M Maruyama; M Kobayashi; Y Iino; M Izuo; S Wakatsuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  Significance of the Tritiated Thymidine Labeling Index in breast cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

6.  Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.

Authors:  B Fisher; E R Fisher; C Redmond; A Brown
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

7.  Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1984-02-15

8.  Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.

Authors:  M Stierer; H Rosen; R Weber; H Hanak; J Spona; H Tüchler
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

9.  Oestrogen receptors in human breast cancer. Problems of correlation with histopathological features.

Authors:  H S Poulsen; L Ozzello; J Andersen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

10.  Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.

Authors:  R Nishimura; A Misumi; M Kimura; T Tokunaga; M Akagi
Journal:  Jpn J Surg       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.